Similarly, PRMT9 significantly inhibited ferroptosis in HCC cells in the presence of HSPA8 WT, whereas the inhibition effect of PRMT9 on ferroptosis was diminished after mutation at R76 and R100 on HSPA8 (Fig. 6B–F). This evidence concerns the gene PRMT9 and hepatocellular carcinoma.